[ASAP] Discovery of Dimethyl Shikonin Oxime 5a, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Type 2 Diabetes Mellitus 🔗 Access full article via ACS Journal of Medicinal Chemistry Journal of Medicinal Chemistry DOI: 10.1021/acs.jmedchem.3c00323 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon